Related references
Note: Only part of the references are listed.Allosteric Binding Sites of the SARS-CoV-2 Main Protease: Potential Targets for Broad-Spectrum Anti-Coronavirus Agents
Lara Alzyoud et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2022)
The Discovery of Small Allosteric and Active Site Inhibitors of the SARS-CoV-2 Main Protease via Structure-Based Virtual Screening and Biological Evaluation
Radwa E. Mahgoub et al.
MOLECULES (2022)
Structural insights into SARS-CoV-2 proteins
Rimanshee Arya et al.
JOURNAL OF MOLECULAR BIOLOGY (2021)
An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19
Dafydd R. Owen et al.
SCIENCE (2021)
Structural Basis of Potential Inhibitors Targeting SARS-CoV-2 Main Protease
Hylemariam Mihiretie Mengist et al.
FRONTIERS IN CHEMISTRY (2021)
Mechanistic insights into COVID-19 by global analysis of the SARS-CoV-2 3CLpro substrate degradome
Isabel Pablos et al.
CELL REPORTS (2021)
Elucidation of Cryptic and Allosteric Pockets within the SARS-CoV-2 Main Protease
Terra Sztain et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2021)
X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease
Sebastian Guenther et al.
SCIENCE (2021)
The dimer-monomer equilibrium of SARS-CoV-2 main protease is affected by small molecule inhibitors
Lucia Silvestrini et al.
SCIENTIFIC REPORTS (2021)
Discovery of chebulagic acid and punicalagin as novel allosteric inhibitors of SARS-CoV-2 3CLpro
Ruikun Du et al.
ANTIVIRAL RESEARCH (2021)
Oxindole and its derivatives: A review on recent progress in biological activities
Yogesh Mahadu Khetmalis et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Dimethyl sulfoxide reduces the stability but enhances catalytic activity of the main SARS-CoV-2 protease 3CLpro
Juliana C. Ferreira et al.
FASEB JOURNAL (2021)
A Crystallographic Snapshot of SARS-CoV-2 Main Protease Maturation Process
G. D. Noske et al.
JOURNAL OF MOLECULAR BIOLOGY (2021)
Interfacial Water Many-Body Effects Drive Structural Dynamics and Allosteric Interactions in SARS-CoV-2 Main Protease Dimerization Interface
Dina El Ahdab et al.
JOURNAL OF PHYSICAL CHEMISTRY LETTERS (2021)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
Linlin Zhang et al.
SCIENCE (2020)
Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy
Bhupesh Goyal et al.
ACS COMBINATORIAL SCIENCE (2020)
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
Zhenming Jin et al.
NATURE (2020)
A Structural View of SARS-CoV-2 RNA Replication Machinery: RNA Synthesis, Proofreading and Final Capping
Maria Romano et al.
CELLS (2020)
Interaction of the prototypical α-ketoamide inhibitor with the SARS-CoV-2 main protease active site in silico: Molecular dynamic simulations highlight the stability of the ligand-protein complex
Julia Liang et al.
COMPUTATIONAL BIOLOGY AND CHEMISTRY (2020)
Discovery of Ketone-Based Covalent Inhibitors of Coronavirus 3CL Proteases for the Potential Therapeutic Treatment of COVID-19
Robert L. Hoffman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease
Alice Douangamath et al.
NATURE COMMUNICATIONS (2020)
Room-temperature X-ray crystallography reveals the oxidation and reactivity of cysteine residues in SARS-CoV-2 3CL Mpro: insights into enzyme mechanism and drug design
Daniel W. Kneller et al.
IUCRJ (2020)
Role of proteolytic enzymes in the COVID-19 infection and promising therapeutic approaches
Magda Gioia et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Structural Analysis and Identification of Colloidal Aggregators in Drug Discovery
Zi-Yi Yang et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2019)
Computational Study of Protein-Ligand Unbinding for Enzyme Engineering
Sergio M. Marques et al.
FRONTIERS IN CHEMISTRY (2019)
Hit optimization studies of 3-hydroxy-indolin-2-one analogs as potential anti-HIV-1 agents
Subhash Chander et al.
BIOORGANIC CHEMISTRY (2018)
SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
Antoine Daina et al.
SCIENTIFIC REPORTS (2017)
Recent progress in the discovery of inhibitors targeting coronavirus proteases
Haofeng Wang et al.
VIROLOGICA SINICA (2016)
Covalent inhibitors in drug discovery: from accidental discoveries to avoided liabilities and designed therapies
Renato A. Bauer
DRUG DISCOVERY TODAY (2015)
PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data
Daniel R. Roe et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2013)
Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group
Raoul J. de Groot et al.
JOURNAL OF VIROLOGY (2013)
3-Alkenyl-oxindoles: Natural Products, Pharmaceuticals, and Recent Synthetic Advances in Tandem/Telescoped Approaches
Alessia Millemaggi et al.
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2010)
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
Jonathan B. Baell et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Correlation between dissociation and catalysis of SARS-CoV main protease
Pei-Ying Lin et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2008)
Lessons learnt from assembling screening libraries for drug discovery for neglected diseases
Ruth Brenk et al.
CHEMMEDCHEM (2008)
Clustering molecular dynamics trajectories: 1. Characterizing the performance of different clustering algorithms
Jianyin Shao et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2007)
Automatic atom type and bond type perception in molecular mechanical calculations
Junmei Wang et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2006)
Drug design targeting the main protease, the Achilles' heel of coronaviruses
Haitao Yang et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
A novel coronavirus associated with severe acute respiratory syndrome
TG Ksiazek et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Molecular properties that influence the oral bioavailability of drug candidates
DF Veber et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Simple selection criteria for drug-like chemical matter
I Muegge et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Prediction of drug absorption using multivariate statistics
WJ Egan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)